Press releases
Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) launches strategic initiative focused on the manufacture of the highly sought after medical isotope Actinium-225 (Ac-225)
14 Mar 24
News, Press Releases
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
7 Feb 24
M&A, News, Press Releases
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
7 Feb 24
Press Releases